KEMTA masterclass: Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
Masterclass
Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
By: Sabine Grimm/Bram Ramaekers
Language: English
The masterclasses will take place via Teams of Zoom. You can register by sending an e-mail to: Irene.vrancken@mumc.nl.
KEMTA (Clinical Epidemiology & Medical Technology Assessment) of MUMC+ regularly organises masterclasses for employees interested in research methods. The masterclasses give short insights into a variety of topics, from the basics of setting up research to statistics and hot topics such as early HTA.
Also read
-
PhD Defence Ammar Ammar
"Enhancing The Interoperability And Reusability Of Nanosafety Data: A Foundation Towards Deeper Insights and Intelligent Applications"
2 Jul -
PhD Defence Berta Hubertina Ganizada
"A systems approach to aortic wall pathology: bridging fundamental research and clinical practice"
2 Jul -
PhD Defence Rekiku Fikre Abebe
"The effect of midwifery-led continuum of care to improve maternal and newborn outcomes in Ethiopia"
2 Jul